Multiple-Dose Pharmacokinetics of Atrasentan, an Endothelin-A Receptor Antagonist
- 1 January 2001
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 21 (2) , 129-136
- https://doi.org/10.2165/00044011-200121020-00005
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Endothelins as Autocrine Regulators of Tumor Cell GrowthTrends in Endocrinology & Metabolism, 1998
- Selective ET A Receptor Antagonism Reduces Neointimal Hyperplasia in a Porcine Coronary Stent ModelCirculation, 1998
- Chronic oral endothelin type A receptor antagonism in experimental heart failure.Hypertension, 1998
- The Orally Active Nonpeptide Endothelin A-Receptor Antagonist A-127722 Prevents and Reverses Hypoxia-Induced Pulmonary Hypertension and Pulmonary Vascular Remodeling in Sprague-Dawley RatsJournal of Cardiovascular Pharmacology, 1997
- EndothelinsNew England Journal of Medicine, 1995
- Endothelin Receptor AntagonismPublished by Elsevier ,1995
- Endothelin-1-induced nociceptionLife Sciences, 1991
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979